Article

PMA submitted for corneal inlay

The final module of the premarket approval application (PMA) for the Kamra corneal inlay to treat presbyopia has been submitted to the FDA by AcuFocus, the inlay’s manufacturer.

 

Irvine, CA-The final module of the premarket approval application (PMA) for the Kamra corneal inlay has been submitted to the FDA by AcuFocus, the inlay’s manufacturer. The corneal inlay is designed to treat presbyopia by allowing only focused light to enter the eye.

“Patients, practitioners, and the ophthalmic industry have all been in search of a reliable corneal solution for presbyopia and I believe the Kamra inlay is that solution,” said John Vukich, MD, an investigator in the U.S. clinical trials.

The inlay is a novel technology with no similar precedent in the market and has undergone rigorous approval processes in several countries. It is now approved in 47 countries across Europe, Asia-Pacific, Middle East, and the Americas.

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
© 2025 MJH Life Sciences

All rights reserved.